glp 1 vs ddp4 Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology 𝐋𝐚𝐭𝐞𝐬𝐭 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐃𝐏𝐏-𝟒 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬

Fatigue: Some participants reported fatigue or tiredness during treatment periods

Citation on PubMed Lahjouji K, Mitchell GA, Qureshi IA

So yeah, I'm so, so fascinated by the telomeres

Liu YK, Ling S, Lui LMW, Ceban F, Vinberg M, Kessing LV, et al

Side effect overlap and what gets worse Both drugs have side effect profiles

Ipamorelin's defining tolerability feature is selectivity: in its foundational pharmacology it stimulated growth-hormone release without meaningfully raising cortisol, prolactin, or ACTH, and without the appetite stimulation seen with other growth-hormone-releasing peptides avoiding several of their characteristic side effects